Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cardiovascular Devices Market

  • MAR2978999
  • 215 Pages
  • February 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Cardiovascular Devices Market was valued at over 33 billion in 2015 and is expected to grow at a CAGR of 6.4% to reach $54.22 billion by the end of 2021. Cardiovascular devices are used to diagnose and treat heart diseases that include numerous problems, most of them related to atherosclerosis. Atherosclerosis is a medication state aroused when a substance called plaque builds up in the walls of the arteries making it harder for the blood to flow thus creating problems.

Market Dynamics

There are various factors that are responsible for the growth in this market such as increase in awareness among population, rapid technological advances, high preference of minimally invasive procedures as these surgeries are less painful, reduce hospital stays, low chances of infections and a faster recovery is there. In addition, cardiovascular devices have a great scope for innovations that will have a strong positive impact on this market in coming few years.

However, there are a few restraints in this market. Stringent regulations and legislations in getting product approvals, lack of skilled healthcare professionals, high cost of cardiovascular devices and their maintenance are some of the restraining factors.

Market Segmentation

The global cardiovascular devices market is segmented by:

Type:

--> Cardiac Rhythm Management Devices

--> Interventional Cardiac Devices

--> Peripheral Vascular Devices

--> Cardiac Pacemakers

--> Cardiac Assist Devices

--> Cardiac Angioplasty Devices

--> Prosthetics (Artificial) Heart Valves

--> Stents

Technology:

--> Minimally Invasive Cardiac Surgery

--> Cardiopulmonary Bypass Products

--> Valve Prosthesis & Repair

Stents hold the major share in the market due to rising demand of minimally invasive surgeries.

Geographic Analysis

North America accounts for the largest market share owing to rising awareness about the treatments, presence of a large patient pool and high disposable incomes. U.S is the leader in the North American market, followed by Canada. Europe, in which Germany, France are some of the largest markets comes after North America. However, Asia-Pacific is the fastest growing market due to increasing number of geriatric population in the region with increasing awareness about various heart diseases. Japan and China will be the largest markets in Asia- Pacific.

Key Companies

Some of the key companies in the market are St. Jude Medical, Medtronic Inc., Abbott Vascular, MAQUET GmbH & Co. KG, EndoPhotonix Inc., Terumo Corporation, C. R. Bard Inc., SEMMT Inc., Cardima Inc. CyberHeart Incorporated, Kardium Inc., MedWaves Incorporated and Boston Scientific Corporation.

The report contains comprehensive analysis on:

--> Cardiovascular Devices Market Segments

--> Cardiovascular Devices Market Drivers, Restraints and Opportunities

--> Cardiovascular Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Cardiovascular Devices Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis Cardiovascular Devices Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390